Journal articles on the topic 'Β1-Blockers'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Β1-Blockers.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage, and Robert J. Hancox. "The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports." ERJ Open Research 7, no. 1 (January 2021): 00801–2020. http://dx.doi.org/10.1183/23120541.00801-2020.
do Vale, Gabriel T., Carla S. Ceron, Natália A. Gonzaga, Janaina A. Simplicio, and Júlio C. Padovan. "Three Generations of β-blockers: History, Class Differences and Clinical Applicability." Current Hypertension Reviews 15, no. 1 (January 29, 2019): 22–31. http://dx.doi.org/10.2174/1573402114666180918102735.
Karoli, N. A., and A. P. Rebrov. "Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease." Kardiologiia 61, no. 10 (October 30, 2021): 89–98. http://dx.doi.org/10.18087/cardio.2021.10.n1119.
Stănciulescu, Maria-Corina, Marius-Călin Popoiu, Anca Maria Cîmpean, Vlad-Laurentiu David, Rodica Heredea, Simona Cerbu, and Eugen-Sorin Boia. "Expression of β1 adrenergic receptor in vascular anomalies in children." Journal of International Medical Research 49, no. 9 (September 2021): 030006052110477. http://dx.doi.org/10.1177/03000605211047713.
Barcella, Carlo A., Talip E. Eroglu, Michiel Hulleman, Asger Granfeldt, Patrick C. Souverein, Grimur H. Mohr, Rudolph W. Koster, et al. "Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries." EP Europace 22, no. 8 (June 28, 2020): 1206–15. http://dx.doi.org/10.1093/europace/euaa124.
Grande, Fedora, Anna De Bartolo, Maria Antonietta Occhiuzzi, Anna Caruso, Carmine Rocca, Teresa Pasqua, Alessia Carocci, Vittoria Rago, Tommaso Angelone, and Maria Stefania Sinicropi. "Carbazole and Simplified Derivatives: Novel Tools toward β-Adrenergic Receptors Targeting." Applied Sciences 11, no. 12 (June 13, 2021): 5486. http://dx.doi.org/10.3390/app11125486.
Artym, Vira V., and Howard R. Petty. "Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and β1-Integrins on the Plasma Membrane of Melanoma Cells." Journal of General Physiology 120, no. 1 (June 10, 2002): 29–37. http://dx.doi.org/10.1085/jgp.20028607.
Singh, Bramah N. "β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview." Journal of Cardiovascular Pharmacology and Therapeutics 10, no. 4_suppl (October 2005): S3—S14. http://dx.doi.org/10.1177/10742484050100i402.
Winther, K., and C. Hedman. "Beta-Adrenoceptor Blockade, Platelets, and Rheologic Factors." Cephalalgia 6, no. 5_suppl (May 1986): 33–40. http://dx.doi.org/10.1177/03331024860060s504.
Diniz, Gabriela Placoná, Marcela Sorelli Carneiro-Ramos, and Maria Luiza Morais Barreto-Chaves. "Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors." International Journal of Endocrinology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/384890.
Clemente-Moragón, Agustín, Mónica Gómez, Rocío Villena-Gutiérrez, Doménica V. Lalama, Jaime García-Prieto, Fernando Martínez, Fátima Sánchez-Cabo, Valentín Fuster, Eduardo Oliver, and Borja Ibáñez. "Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation." European Heart Journal 41, no. 46 (October 7, 2020): 4425–40. http://dx.doi.org/10.1093/eurheartj/ehaa733.
Nuttall, S. L., H. C. Routledge, and M. J. Kendall. "A comparison of the β1 -selectivity of three β1 -selective β-blockers." Journal of Clinical Pharmacy and Therapeutics 28, no. 3 (June 2003): 179–86. http://dx.doi.org/10.1046/j.1365-2710.2003.00477.x.
WAJIMA, Zen'ichiro. "Future Possibilities for the Clinical Use of β1-blockers." JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 26, no. 4 (2006): 398–403. http://dx.doi.org/10.2199/jjsca.26.398.
Nakaya, Michio, Satsuki Chikura, Kenji Watari, Natsumi Mizuno, Koji Mochinaga, Supachoke Mangmool, Satoru Koyanagi, et al. "Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways." Journal of Biological Chemistry 287, no. 42 (August 10, 2012): 35669–77. http://dx.doi.org/10.1074/jbc.m112.357871.
Áblad, Bengt, and Carl Dahlöf. "Migraine and β-Blockade: Modulation of Sympathetic Neurotransmission." Cephalalgia 6, no. 5_suppl (May 1986): 7–14. http://dx.doi.org/10.1177/03331024860060s501.
Blaauw, Erik, Frans A. van Nieuwenhoven, Peter Willemsen, Tammo Delhaas, Frits W. Prinzen, Luc H. Snoeckx, Marc van Bilsen, and Ger J. van der Vusse. "Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes." American Journal of Physiology-Heart and Circulatory Physiology 299, no. 3 (September 2010): H780—H787. http://dx.doi.org/10.1152/ajpheart.00822.2009.
Ashes, Catherine, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare, and W. Scott Beattie. "Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol." Anesthesiology 119, no. 4 (October 1, 2013): 777–87. http://dx.doi.org/10.1097/aln.0b013e3182a17f12.
Peltenburg, Puck J., Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy, et al. "An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia." Circulation 145, no. 5 (February 2022): 333–44. http://dx.doi.org/10.1161/circulationaha.121.056018.
Durgaryan, Ruzan. "C0159 β1 blockers, warfarin and rhythm conversion in atrial fibrillation." Thrombosis Research 130 (October 2012): S173. http://dx.doi.org/10.1016/j.thromres.2012.08.188.
Fedorov, V. N., V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov, and S. S. Suleymanov. "Pharmacotherapy of glaucoma in terms of evidence-based medicine." Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, no. 3 (October 20, 2023): 44–54. http://dx.doi.org/10.37489/2588-0519-2023-3-44-54.
Geng, Yanyan, Xiaoyu Wang, and Karl L. Magleby. "Lack of negative slope in I-V plots for BK channels at positive potentials in the absence of intracellular blockers." Journal of General Physiology 141, no. 4 (March 25, 2013): 493–97. http://dx.doi.org/10.1085/jgp.201210955.
Yi, Sheng, Fernando Pierucci-Alves, and Bruce D. Schultz. "Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway." American Journal of Physiology-Cell Physiology 305, no. 8 (October 15, 2013): C867—C876. http://dx.doi.org/10.1152/ajpcell.00121.2013.
Casabella-Ramón, Sergi, Verónica Jiménez-Sábado, Carmen Tarifa, Sandra Casellas, Tien Tina Lu, Paloma Izquierdo-Castro, Ignasi Gich, et al. "Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes." Biomedicines 10, no. 7 (July 21, 2022): 1759. http://dx.doi.org/10.3390/biomedicines10071759.
Farhoumand, Lina S., Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis, and Utta Berchner-Pfannschmidt. "Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures." International Journal of Molecular Sciences 24, no. 6 (March 20, 2023): 5894. http://dx.doi.org/10.3390/ijms24065894.
Wydra, Wioletta, and Marek Kuch. "Nebivolol – a place in the therapy of hypertension in various clinical situations." Medycyna Faktów 14, no. 2 (June 30, 2021): 195–200. http://dx.doi.org/10.24292/01.mf.0221.9.
Verdecchia, Paolo, Claudio Cavallini, Stefano Coiro, Clara Riccini, and Fabio Angeli. "Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease." European Heart Journal Supplements 23, Supplement_E (October 1, 2021): E172—E176. http://dx.doi.org/10.1093/eurheartj/suab116.
Floria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi, et al. "An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation." Pharmaceutics 16, no. 4 (April 8, 2024): 517. http://dx.doi.org/10.3390/pharmaceutics16040517.
Schnabel, Petra, Christoph Maack, Florian Mies, Stephan Tyroller, Alexander Scheer, and Michael Böhm. "Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors." Journal of Cardiovascular Pharmacology 36, no. 4 (October 2000): 466–71. http://dx.doi.org/10.1097/00005344-200010000-00008.
Mizogami, Maki, Ko Takakura, and Hironori Tsuchiya. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers." European Journal of Anaesthesiology 27, no. 9 (September 2010): 829–34. http://dx.doi.org/10.1097/eja.0b013e32833bf5e4.
&NA;. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers." European Journal of Anaesthesiology 29, no. 5 (May 2012): 255. http://dx.doi.org/10.1097/eja.0b013e328353b02b.
Brizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni, and Paola Massarelli. "Synthesis, binding affinity and selectivity of new β1- and β2-adrenoceptor blockers." Il Farmaco 54, no. 11-12 (November 1999): 713–20. http://dx.doi.org/10.1016/s0014-827x(99)00077-4.
Rizos, Ioannis K., James N. Tsoporis, Ioannis K. Toumpoulis, Vasileios Salpeas, Shehla Izhar, Angelos G. Rigopoulos, Eleftherios A. Sakadakis, and Thomas G. Parker. "Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells." Journal of Cardiovascular Pharmacology 72, no. 2 (August 2018): 86–96. http://dx.doi.org/10.1097/fjc.0000000000000596.
Chaudhari, Sarika, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E. Davis, Jonathan E. Zuckerman, and Rong Ma. "Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells." American Journal of Physiology-Renal Physiology 313, no. 3 (September 1, 2017): F729—F739. http://dx.doi.org/10.1152/ajprenal.00483.2016.
Kähönen, Mika, Ritva Ylitalo, Tiit Kööbi, Väinö Turjanmaa, and Pauli Ylitalo. "Influences of nonselective, β1-selective and vasodilatory β1-selective β-blockers on arterial pulse wave velocity in normotensive subjects." General Pharmacology: The Vascular System 35, no. 4 (October 2000): 219–24. http://dx.doi.org/10.1016/s0306-3623(01)00109-4.
Miaron, J. O. O., and R. J. Christopherson. "Metabolic responses of the whole body, portal-drained viscera and hindquarter to adrenaline infusion: Effects of nonselective and selective β-adrenoceptor blockade." Canadian Journal of Animal Science 77, no. 2 (June 1, 1997): 307–16. http://dx.doi.org/10.4141/a94-082.
Zhang, Y. Clare, Leping Shen, and M. Ian Phillips. "An Antisense β1-Reducer: Repeated Administration Reduces Hypertension and Cardiac Hypertrophy Persistently Without Toxicity or Immune Response." Hypertension 36, suppl_1 (October 2000): 691. http://dx.doi.org/10.1161/hyp.36.suppl_1.691.
Ongali, Brice, Nektaria Nicolakakis, Xin-Kang Tong, Clotilde Lecrux, Hans Imboden, and Edith Hamel. "Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways." Canadian Journal of Physiology and Pharmacology 96, no. 5 (May 2018): 527–34. http://dx.doi.org/10.1139/cjpp-2017-0640.
Park, Soo Hyun, and Ho Jae Han. "The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells." American Journal of Physiology-Renal Physiology 282, no. 2 (February 1, 2002): F228—F237. http://dx.doi.org/10.1152/ajprenal.00080.2001.
Ozakca, Isil, Ebru Arioglu-Inan, Hrag Esfahani, V. Melih Altan, Jean-Luc Balligand, Gizem Kayki-Mutlu, and A. Tanju Ozcelikay. "Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage." American Journal of Physiology-Heart and Circulatory Physiology 304, no. 9 (May 1, 2013): H1267—H1276. http://dx.doi.org/10.1152/ajpheart.00352.2012.
Kruik-Kollöffel, Willemien J., Job van der Palen, Carine J. M. Doggen, Marissa C. van Maaren, H. Joost Kruik, Edith M. Heintjes, Kris L. L. Movig, and Gerard C. M. Linssen. "Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases." PLOS ONE 15, no. 12 (December 22, 2020): e0244231. http://dx.doi.org/10.1371/journal.pone.0244231.
Gutierrez, Guillermo, and Guillermo Ballarino. "Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!" Intensive Care Medicine 37, no. 11 (August 17, 2011): 1721–22. http://dx.doi.org/10.1007/s00134-011-2330-1.
Nemoto, Shinji, Yusuke Kasahara, Kazuhiro P. Izawa, Satoshi Watanabe, Kazuya Yoshizawa, Naoya Takeichi, Kentaro Kamiya, et al. "Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction." International Journal of Environmental Research and Public Health 16, no. 16 (August 8, 2019): 2838. http://dx.doi.org/10.3390/ijerph16162838.
Brahmbhatt, Shruti Vihang, and Bhagya M. Sattigeri. "A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital." International Journal of Basic & Clinical Pharmacology 7, no. 11 (October 23, 2018): 2196. http://dx.doi.org/10.18203/2319-2003.ijbcp20184327.
Pillozzi, Serena, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei, et al. "Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers." Blood 117, no. 3 (January 20, 2011): 902–14. http://dx.doi.org/10.1182/blood-2010-01-262691.
Polakovičová, M., and R. Čižmáriková. "Molecular Docking Study on the Binding Mode of Cardioselective Phenoxyaminopropanol Blocker into β-adrenergic Receptor Subtypes." Acta Facultatis Pharmaceuticae Universitatis Comenianae 59, no. 2 (December 28, 2012): 44–53. http://dx.doi.org/10.2478/v10219-012-0024-6.
Ahmed, Maruf, Habib Abul Muntasir, Murad Hossain, Masaji Ishiguro, Tadazumi Komiyama, Ikunobu Muramatsu, Hitoshi Kurose, and Takafumi Nagatomo. "Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor." Journal of Pharmacological Sciences 102, no. 2 (2006): 167–72. http://dx.doi.org/10.1254/jphs.fp0060640.
Song, Hong Ji, Joongyub Lee, Ye-Jee Kim, Sun-Young Jung, Hwa Jung Kim, Nam-Kyong Choi, and Byung-Joo Park. "β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients." Bone 51, no. 6 (December 2012): 1008–15. http://dx.doi.org/10.1016/j.bone.2012.08.126.
Brizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni, and Paola Massarelli. "ChemInform Abstract: Synthesis, Binding Affinity, and Selectivity of New β1- and β2-Adrenoceptor Blockers." ChemInform 31, no. 12 (June 9, 2010): no. http://dx.doi.org/10.1002/chin.200012248.
Jia, Haiyan, Sue Monteith, and Morris J. Brown. "Expression of the α- and β-Subunits of the Stimulatory and Inhibitory G-Proteins in β1-Adrenoceptor-Blocked and non-β-Adrenoceptor-Blocked Human Atrium." Clinical Science 88, no. 5 (May 1, 1995): 571–80. http://dx.doi.org/10.1042/cs0880571.
Gao, Xiaomeng, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa, Fan Yang, and Qingyou Xu. "Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice." International Journal of Molecular Sciences 24, no. 14 (July 21, 2023): 11766. http://dx.doi.org/10.3390/ijms241411766.